As of 2026-10-30, the Relative Valuation of Axsome Therapeutics Inc (AXSM) is (114.89) USD. This relative valuation is based on P/E multiples. With the latest stock price at 143.45 USD, the upside of Axsome Therapeutics Inc based on Relative Valuation is -180.1%.
The range of the Relative Valuation is (69.57) - (86.92) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 40.8x | 39.4x |
| Forward P/E multiples | 16.4x - 23.3x | 22.3x |
| Fair Price | (69.57) - (86.92) | (114.89) |
| Upside | -148.5% - -160.6% | -180.1% |
| Date | P/E |
| 2026-10-28 | -38.54 |
| 2026-10-27 | -38.18 |
| 2026-10-26 | -38.68 |
| 2026-10-23 | -38.95 |
| 2026-10-22 | -41.91 |
| 2026-10-21 | -41.97 |
| 2026-10-20 | -42.85 |
| 2026-10-19 | -41.84 |
| 2026-10-16 | -42.20 |
| 2026-10-15 | -43.44 |
| 2026-10-14 | -43.56 |
| 2026-10-13 | -41.97 |
| 2026-10-12 | -44.57 |
| 2026-10-09 | -45.21 |
| 2026-10-08 | -45.67 |
| 2026-10-07 | -46.45 |
| 2026-10-06 | -46.81 |
| 2026-10-05 | -47.55 |
| 2026-10-02 | -48.13 |
| 2026-10-01 | -48.89 |
| 2026-09-30 | -49.51 |
| 2026-09-29 | -49.98 |
| 2026-09-28 | -52.06 |
| 2026-09-25 | -52.39 |
| 2026-09-24 | -52.64 |
| 2026-09-23 | -51.94 |
| 2026-09-22 | -54.54 |
| 2026-09-21 | -55.18 |
| 2026-09-18 | -55.79 |
| 2026-09-17 | -57.54 |
| 2026-09-16 | -56.92 |
| 2026-09-15 | -54.80 |
| 2026-09-14 | -58.16 |
| 2026-09-11 | -59.28 |
| 2026-09-10 | -56.69 |
| 2026-09-09 | -56.56 |
| 2026-09-08 | -55.80 |
| 2026-09-04 | -55.50 |
| 2026-09-03 | -55.95 |
| 2026-09-02 | -56.37 |
| 2026-09-01 | -54.46 |
| 2026-08-31 | -53.31 |
| 2026-08-28 | -53.44 |
| 2026-08-27 | -55.39 |
| 2026-08-26 | -55.62 |
| 2026-08-25 | -55.18 |
| 2026-08-24 | -55.15 |
| 2026-08-21 | -55.79 |
| 2026-08-20 | -55.86 |
| 2026-08-19 | -58.59 |